Viral hepatitis is a major danger to public health. According to WHO’s 2024 Global Hepatitis Report, viral hepatitis deaths increased from 1.1 million in 2019 to 1.3 million in 2022, rates now ...

The FDA has removed semaglutide from its drug shortage list after the agency determined the current supply of the drug can ...

The American Heart Association and American College of Cardiology issued a scientific statement detailing clinical guidance ...

Adolescents in the United States with symptoms of ADHD had a higher likelihood of using tobacco and other nicotine-based ...

The presentation of Cushing’s disease varies by age, with older adults having fewer hallmark features of the condition and ...

The investigational new drug application for Zabalafin Hydrogel for the treatment of mild to moderate atopic dermatitis has ...

As we approach the first anniversary of omalizumab’s approval for food allergy, its use is “definitely going to grow,” Robert ...

Researchers’ understanding of the pathogenesis of rheumatoid arthritis has grown considerably in recent years, laying the ...

The latest data from The Vision Council’s Market inSights report indicate that the proportion of contact lenses and glasses ...

Women caregivers are more likely to report emotional stress, struggles with work-life balance and depression or anxiety ...

Paxlovid may not decrease the risk for hospitalization or death in older adults vaccinated against COVID-19 as much as ...

A retrospective study demonstrated that GLP-1 receptor agonist use before pregnancy corresponded with lower risks for ...